Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Gerson Company is a privately held U.S. manufacturer of respiratory protective equipment and related industrial consumables. Founded in 1956, the company is best known for N95, N99, R95, and P100 respirators, reusable half-mask and full-face respirators, cartridges and filters, as well as paint strainers and tack cloths. Gerson describes itself as a vertically integrated manufacturer, producing filtering facepiece respirators in Middleborough, Massachusetts and using company-designed equipment and proprietary melt-blown filtration media. Its products are marketed for industrial, painting, welding, dust, silica, mold, and healthcare-related respiratory protection applications, with certain respirators carrying NIOSH and/or FDA approvals. The business appears to be a commercial-stage medtech/PPE manufacturer rather than a drug-development biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Gerson Company.